Disease control should be the goal of therapy for WM patients

類似資料

• What should be the goal of therapy for Waldenström macroglobulinemia patients? Complete response should be the goal of therapy
  著者:: Treon, Steven P., 等
  出版事項: (2017)
• How I treat rituximab refractory patients with WM
  著者:: Gavriatopoulou, Maria, 等
  出版事項: (2018)
• Systemic autoimmune diseases, anti-rheumatic therapies, COVID-19 infection risk and patient outcomes
  著者:: Kastritis, Efstathios, 等
  出版事項: (2020)
• Should minimal residual disease negativity not be the end point of myeloma therapy?
  著者:: Sonneveld, Pieter
  出版事項: (2017)
• Should minimal residual disease negativity be the end point of myeloma therapy?
  著者:: Anderson, Kenneth C.
  出版事項: (2017)